Why the Injector Matters
Aesthetic products are largely standardised. The same Juvederm, the same Botox, the same devices are available to practices across Los Angeles. What differs enormously is judgement.
Dr. Daniel Moghadam is the founder and medical director of Modern Aesthetica, and he performs the treatments himself. He is not a supervising signature for a technician working from a template — he is the person assessing your anatomy and deciding placement.
Where that difference shows
In dosing judgement. Forehead strength varies enormously between patients. A standard 20 units leaves one patient unchanged and another heavy-browed. Reading how a face actually moves is not something a protocol captures.
In anatomical safety. The most serious filler complication is vascular occlusion — product entering a blood vessel and obstructing flow, which can cause tissue loss or, very rarely, vision loss. Risk is reduced by understanding the vascular anatomy, injecting slowly at low pressure, and recognising a problem immediately. This matters most in high-risk areas like the nose and tear trough.
In saying no. A physician has no commercial reason to treat someone who should not be treated. Patients regularly leave here with a smaller plan than they arrived expecting, or with a recommendation for surgery, or with advice to wait.
In breadth. Because the practice also provides hormone therapy, medical weight loss and regenerative treatment, the answer to a cosmetic complaint is sometimes a medical one.
